New TNF-α releasing inhibitors as cancer preventive agents from traditional herbal medicine and combination cancer prevention study with EGCG and sulindac or tamoxifen

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 523-524, Issue , 2003, Pages 119-125

  Fujiki, Hirota ^a   Suganuma, Masami ^b   Kurusu, Miki ^b   Okabe, Sachiko ^b   Imayoshi, Yoko ^c   Taniguchi, Shoko ^c   Yoshida, Takashi ^c  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^b SAITAMA CANCER CENTER   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

EGCG; Sulindac; Tamoxifen; TNF releasing inhibitors

Indexed keywords

ACER NIKOENSE EXTRACT; CORILAGIN; EPIGALLOCATECHIN GALLATE; GERANIIN; GERANIUM THUNBERGII EXTRACT; OKADAIC ACID; PLANT EXTRACT; POLYPHENOL DERIVATIVE; SULINDAC; TAMOXIFEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACER NIKOENSE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; CANCER PREVENTION; CARCINOGENESIS; CELL STRAIN; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG POTENTIATION; GENE EXPRESSION; GERANIUM THUNBERGII; HERBAL MEDICINE; INTESTINE CARCINOMA; JAPAN; MALE; MEDICINAL PLANT; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PLANT LEAF; PRIORITY JOURNAL; SEASONAL VARIATION;

ACER; ACER MAXIMOWICZIANUM; GERANIUM THUNBERGII;

EID: 0037292963     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(02)00327-5     Document Type: Conference Paper

References (25)

1. Fujiki H. Two stages of cancer prevention with green tea. J. Cancer Res. Clin. Oncol. 125:1999;589-597.
2. Okabe S., Sueoka N., Komori A., Suganuma M., Endo Y., Shudo K., Fujiki H. Twist form of teleocidin derivatives is active in in vivo tumor promotion by (-)-benzolactam-V8-310. Biol. Pharmacol. Bull. 21:1998;465-468.
3. Sakai A., Fujiki H. Promotion of BALB/3T3 cell transformation by the okadaic acid class of tumor promoters, okadaic acid and dinophysistoxin-1. Jpn. J. Cancer Res. 82:1991;518-523.
4. Komori A., Yatsunami J., Suganuma M., Okabe S., Abe S., Sakai A., Sasaki K., Fujiki H. Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation. Cancer Res. 53:1993;1982-1985.
5. Suganuma M., Okabe S., Marino M.W., Sakai A., Sueoka E., Fujiki H. Essential role of tumor necrosis factor-α (TNF-α) in tumor promotion as revealed by TNF-α-deficient mice. Cancer Res. 59:1999;4516-4518.
6. Moore R.J., Owens D.M., Stamp G., Arnott C., Burke F., East N., Holdsworth H., Turner L., Rollins B., Pasparakis M., Kollias G., Balkwill F. Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis. Nat. Med. 5:1999;828-831.
7. Suganuma M., Okabe S., Kurusu M., Iida N., Ohshima S., Saeki Y., Kishimoto T., Fujiki H. Discrete roles of cytokines, TNF-α, IL-1, IL-6 in tumor promotion and cell transformation. Int. J. Oncol. 20:2002;131-136.
8. Barnes P.J., Karin M. Nuclear factor-κB - a pivotal transcription factor in chronic inflammatory diseases. New Engl. J. Med. 336:1997;1066-1071.
9. Okabe S., Ochiai Y., Aida M., Park K., Kim S.-J., Nomura T., Suganuma M., Fujiki H. Mechanistic aspects of green tea as a cancer preventive: effect of components on human stomach cancer cell lines. Jpn. J. Cancer Res. 90:1999;733-739.
10. Okabe S., Suganuma M., Imayoshi Y., Taniguchi S., Yoshida T., Fujiki H. New TNF-α releasing inhibitors, geraniin and corilagin, in leaves of Acer nikoense, Megusurino-ki. Biol. Pharmacol. Bull. 24:2001;1145-1148.
11. Suganuma M., Okabe S., Sueoka E., Iida N., Komori A., Kim S.-J., Fujiki H. A new process of cancer prevention mediated through inhibition of tumor necrosis factor-α expression. Cancer Res. 56:1996;3711-3715.
12. Suganuma M., Okabe S., Sueoka N., Sueoka E., Matsuyama S., Imai K., Nakachi K., Fujiki H. Green tea and cancer chemoprevention. Mutat. Res. 428:1999;339-344.
13. Okabe S., Fujimoto N., Sueoka N., Suganuma M., Fujiki H. Modulation of gene expression by (-)-epigallocatechin gallate in PC-9 cells using a cDNA expression array. Biol. Pharmacol. Bull. 24:2001;883-886.
14. Fisher B., Costantino J.P., Wickerham D.L., Redmond C.K., Kavanah M., Cronin W.M., Vogel V., Robidoux A., Dimitrov N., Atkins J., Daly M., Wieand S., Tan-Chiu E., Ford L., Wolmark N. National surgical adjuvant breast and bowel project investigators, tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 study. J. Natl. Cancer Inst. 90:1998;1371-1388.
15. Torrance C.J., Jackson P.E., Montgomery E., Kinzler K.W., Vogelstein B., Wissner A., Nunes M., Frost P., Discafani C.M. Combinatorial chemoprevention of intestinal neoplasia. Nat. Med. 6:2000;1024-1028.
16. Suganuma M., Okabe S., Kai Y., Sueoka N., Sueoka E., Fujiki H. Synergistic effects of (-)-epigallocatechin gallate with (-)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. Cancer Res. 59:1999;44-47.
17. Suganuma M., Ohkura Y., Okabe S., Fujiki H. Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal tumor formation in Min mice. J. Cancer Res. Clin. Oncol. 127:2001;69-72.
18. Okuda T., Yoshida T., Hatano T., Ikeda Y. Biomimetic synthesis of elaeocarpusin. Heterocycles. 24:1986;1841-1843.
19. Okuda T., Yoshida T., Hatano T. Constituents of Geranium thunbergii Sieb. et Zucc. Part 12. Hydrated stereostructure and equilibration of geraniin. J. Chem. Soc., Perkin Trans. 1:1982;9-14.
20. Okuda T., Mori K., Ishino M. Constituents of Geranium thunbergii Sieb. et Zucc. VIII, transformations of geraniin upon decoction. Yakugaku Zasshi. 99:1979;543-545.
21. S. Yoshizawa, T. Horiuchi, M. Suganuma, S. Nishiwaki, J. Yatunami, S. Okabe, T. Okuda, Y. Muto, K. Frenkel, W. Troll, H. Fujiki, Penta-O-galloyl-β-D-glucose and (-)-epigallo-catechin gallate cancer preventive agents, in: M.-T. Huang, C.-T. Ho, C.Y. Lee (Eds.), Phenolic Compounds in Food and Their Effects on Health II, Proceedings of the ACS Symposium Series 507, Antioxidants and Cancer Prevention, American Chemical Society, Washington, DC, 1992, pp. 316-325.
22. Okuda T., Mori K., Hatano T. The distribution of geraniin and mallotusinic acid in the order geraniales. Phytochemistry. 19:1980;547-551.
23. Fujiki H., Suganuma M., Okabe S., Sueoka E., Sueoka N., Fumimoto N., Goto Y., Matsuyama S., Imai K., Nakachi K. Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1. Mutat. Res. 480-481:2001;299-304.
24. Suganuma M., Sueoka E., Sueoka N., Okabe S., Fujiki H. Mechanisms of cancer prevention by tea polyphenols based on inhibition of TNF-α expression. Biofactors. 13:2000;67-72.
25. Sporn M.B. Combination chemoprevention of cancer. Nature. 287:1980;107-108.